Department of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC, United States; George Washington Cancer Center, George Washington University, Washington, DC, United States.
Vaccine. 2020 Sep 22;38(41):6388-6401. doi: 10.1016/j.vaccine.2020.07.059. Epub 2020 Aug 20.
Asian-Americans have been documented to have low human papillomavirus (HPV) vaccine initiation and completion. No research has attempted to examine underlying mechanisms of HPV vaccine uptake disparities among Asian-Americans. Using the P3 (practice, provider, and patient) model, this study aimed to identify practice-, provider-, and patient-level determinants of Asian-Americans' HPV vaccine intention and uptake.
We conducted a systematic review of published literature regarding practice-, provider- and patient-level determinants of vaccine intention (e.g., intention, willingness, or acceptability) and uptake (e.g., initiation or completion). Eligible studies were those presenting empirical/original data, focusing on Asian populations in the U.S., including outcomes related to HPV vaccine intention and uptake, and analyzing data on factors associated with these outcomes separately for Asian groups.
Twenty-six studies (19 quantitative and 7 qualitative studies) were included in the review. Most commonly studied subgroups were Koreans (n = 9), Chinese (n = 6), and Cambodians (n = 5). Studies showed varied prevalence across subgroups (intention: 23.4%-72%; initiation: 14%-67%; completion: 9%-63%). Only 3 studies included measurements of practice-level determinants (language services, insurance policy). Twelve studies measured provider-level determinants (most commonly documented: HPV vaccine recommendation). All studies measured patient-level determinants (most commonly documented: HPV and HPV vaccine knowledge, perceived safety, perceived susceptibility, and perceived relationship between HPV vaccine and sexual activity).
Existing research on determinants of HPV vaccine intention and uptake among Asian-Americans currently lacks measurements of practice-level constructs and perspectives of clinic staff and providers, which are needed to guide system-level interventions and provider training. Data regarding patient-level determinants suggest that interventions for Asian-American populations can focus on providing educational information in culturally-appropriate manners, leveraging familial influences, and attending to access-related or cultural beliefs about HPV vaccine. Interventions should take into account varied vaccine intention and uptake prevalence in different Asian subgroups.
已记录到亚裔美国人的人乳头瘤病毒 (HPV) 疫苗接种启动率和完成率较低。目前尚无研究试图探讨亚裔美国人 HPV 疫苗接种率差异的潜在机制。本研究使用 P3(实践、提供者和患者)模型,旨在确定影响亚裔美国人 HPV 疫苗接种意向和接种率的实践、提供者和患者层面的决定因素。
我们对已发表的关于影响疫苗接种意向(如意愿、接受度)和接种率(如启动或完成)的实践、提供者和患者层面决定因素的文献进行了系统回顾。符合条件的研究是指那些提供实证/原始数据、以美国亚裔人群为研究对象、包含与 HPV 疫苗接种意向和接种率相关的研究结果、并分别分析与这些结果相关的因素数据的研究。
本研究共纳入 26 项研究(19 项定量研究和 7 项定性研究)。研究中最常见的亚组是韩国人(n=9)、中国人(n=6)和柬埔寨人(n=5)。各亚组的研究结果存在差异(意向:23.4%-72%;启动:14%-67%;完成:9%-63%)。仅有 3 项研究包含实践层面决定因素的测量(语言服务、保险政策)。12 项研究测量了提供者层面的决定因素(最常记录的:HPV 疫苗推荐)。所有研究均测量了患者层面的决定因素(最常记录的:HPV 和 HPV 疫苗知识、感知安全性、感知易感性以及 HPV 疫苗与性行为之间的关系)。
目前,关于亚裔美国人 HPV 疫苗接种意向和接种率的决定因素的研究缺乏对实践层面结构和医疗机构工作人员及提供者观点的测量,这些是指导系统层面干预和提供者培训所必需的。关于患者层面决定因素的数据表明,针对亚裔人群的干预措施可以集中在以文化适宜的方式提供教育信息、利用家庭影响,并关注与 HPV 疫苗相关的获取途径或文化信念。干预措施应考虑到不同亚裔亚组之间不同的疫苗接种意向和接种率的流行率。